OrbiMed Advisors »

Monopar Therapeutics shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $15M 157k 92.59

More positions owned by OrbiMed Advisors

Edgewise Therapeutics (EWTX)
Enliven Therapeutics (ELVN)
Eli Lilly & Co. (LLY)
Mbx Biosciences (MBX)
Sinovac Biotech SHS
Astrazeneca Ord (AZN)
Structure Therapeutics Sponsored Ads (GPCR)
Sionna Therapeutics (SION)
Corvus Pharmaceuticals (CRVS)
Arrivent Biopharma (AVBP)
Abivax Sa Sponsored Ads Call Option (ABVX)
Guardant Health (GH)
Argenx Se Sponsored Adr (ARGX)
Merck & Co (MRK)
Uniqure Nv SHS (QURE)

View all positions for OrbiMed Advisors

Top funds holding Monopar Therapeutics

Henderson Group
Jupiter Topco
RA Capital Management
BlackRock
Deerfield Management Company
Saturn V Capital Management
Siren
ADAR1 Capital Management
Polar Capital Holdings
Vanguard Capital Management
Adage Capital Partners GP
TCG Crossover Management
Wellington Management Company
OrbiMed Advisors
Candriam Luxembourg S.C.A.

View all funds holding Monopar Therapeutics